首页 > 最新文献

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association最新文献

英文 中文
Endocrine Complications in Hepatic Glycogen Storage Diseases: A Long-term Perspective. 肝糖原贮积症的内分泌并发症:长期展望
Ja Hye Kim, Yena Lee, Soojin Hwang, Dohyung Kim, Beom Hee Lee, Gu-Hwan Kim, Han-Wook Yoo, Jin-Ho Choi

Objective: Patients with hepatic type of glycogen storage diseases (GSDs) can manifest endocrine features such as hypoglycemia, dyslipidemia, or osteoporosis. This study aimed to investigate the long-term endocrine consequences in patients with hepatic GSDs.

Methods: This study included 64 patients from 52 families with hepatic GSDs including GSD type Ia (41 patients from 37 families), Ib (3 unrelated), III (8 from 6 families), IV (one patient), and IX (11 from 5 families). All patients were genetically confirmed. Clinical and endocrine findings were retrospectively analyzed.

Results: The median age at diagnosis and current age were 2.4 years (range, 0.1-42.4 years) and 17.6 years (range, 1.0-47.8 years), respectively. The mean height SDS at diagnosis was -3.5 ± 1.4, and short stature was observed in 35.6% of patients. Patients diagnosed after the age of 3.4 years exhibited a high risk of short stature (OR = 36.1; P-value < 0.001). Among 33 patients who reached final height, 23 (69.7%) showed delayed puberty. Hypertriglyceridemia was observed in 46 patients (71.9%), whereas 25 patients (39%) had elevated low-density lipoprotein cholesterol levels during the follow-up period. Among 24 patients who underwent dual energy X-ray absorptiometry, 22 showed a low bone mineral density Z-score of -3.0 ± 1.3 at the L-spine.

Conclusions: This study described the long-term endocrine consequences in patients with hepatic GSDs. Pediatric endocrinologists should be aware of the presenting features and long-term endocrine sequelae of GSDs to provide proper management and decrease its morbidities.

目的:肝型糖原贮积症(GSDs)患者可表现出低血糖、血脂异常或骨质疏松症等内分泌特征。本研究旨在探讨肝型糖原贮积症患者的长期内分泌后果:本研究纳入了 52 个家族的 64 名肝 GSD 患者,包括 GSD Ia 型(37 个家族中的 41 名患者)、Ib 型(3 个无亲属关系)、III 型(6 个家族中的 8 名患者)、IV 型(1 名患者)和 IX 型(5 个家族中的 11 名患者)。所有患者均经基因证实。对临床和内分泌检查结果进行了回顾性分析:诊断时的中位年龄和目前年龄分别为 2.4 岁(0.1-42.4 岁)和 17.6 岁(1.0-47.8 岁)。确诊时的平均身高 SDS 为 -3.5 ± 1.4,35.6% 的患者身材矮小。3.4 岁以后确诊的患者出现身材矮小的风险较高(OR = 36.1;P 值 < 0.001)。在 33 名达到最终身高的患者中,有 23 人(69.7%)出现青春期延迟。在随访期间,46 名患者(71.9%)出现高甘油三酯血症,25 名患者(39%)出现低密度脂蛋白胆固醇水平升高。在接受双能 X 射线吸收测量的 24 名患者中,22 名患者的左侧脊柱骨矿密度 Z 值为-3.0 ± 1.3:本研究描述了肝脏GSD患者的长期内分泌后果。结论:本研究描述了肝脏 GSD 患者的长期内分泌后果,儿科内分泌专家应了解 GSD 的表现特征和长期内分泌后遗症,以提供适当的治疗,减少其发病率。
{"title":"Endocrine Complications in Hepatic Glycogen Storage Diseases: A Long-term Perspective.","authors":"Ja Hye Kim, Yena Lee, Soojin Hwang, Dohyung Kim, Beom Hee Lee, Gu-Hwan Kim, Han-Wook Yoo, Jin-Ho Choi","doi":"10.1055/a-2444-4320","DOIUrl":"https://doi.org/10.1055/a-2444-4320","url":null,"abstract":"<p><strong>Objective: </strong>Patients with hepatic type of glycogen storage diseases (GSDs) can manifest endocrine features such as hypoglycemia, dyslipidemia, or osteoporosis. This study aimed to investigate the long-term endocrine consequences in patients with hepatic GSDs.</p><p><strong>Methods: </strong>This study included 64 patients from 52 families with hepatic GSDs including GSD type Ia (41 patients from 37 families), Ib (3 unrelated), III (8 from 6 families), IV (one patient), and IX (11 from 5 families). All patients were genetically confirmed. Clinical and endocrine findings were retrospectively analyzed.</p><p><strong>Results: </strong>The median age at diagnosis and current age were 2.4 years (range, 0.1-42.4 years) and 17.6 years (range, 1.0-47.8 years), respectively. The mean height SDS at diagnosis was -3.5 ± 1.4, and short stature was observed in 35.6% of patients. Patients diagnosed after the age of 3.4 years exhibited a high risk of short stature (OR = 36.1; P-value < 0.001). Among 33 patients who reached final height, 23 (69.7%) showed delayed puberty. Hypertriglyceridemia was observed in 46 patients (71.9%), whereas 25 patients (39%) had elevated low-density lipoprotein cholesterol levels during the follow-up period. Among 24 patients who underwent dual energy X-ray absorptiometry, 22 showed a low bone mineral density Z-score of -3.0 ± 1.3 at the L-spine.</p><p><strong>Conclusions: </strong>This study described the long-term endocrine consequences in patients with hepatic GSDs. Pediatric endocrinologists should be aware of the presenting features and long-term endocrine sequelae of GSDs to provide proper management and decrease its morbidities.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142484052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update. 从纳尔逊综合征到皮质营养肿瘤进展速度:最新进展。
Laura Bessiène, Chiara Villa, Xavier Bertagna, Bertrand Baussart, Guillaume Assié

Since the first description of Nelson syndrome 60 years ago, the way to consider corticotroph pituitary neuroendocrine tumors (PitNETs) after bilateral adrenalectomy has evolved. Today, it is globally acknowledged that only a subset of corticotroph PitNETs is aggressive.After adrenalectomy, corticotroph tumor progression (CTP) occurs in about 30 to 40% of patients during a median follow-up of 10 years. When CTP occurs, various CTP speeds (CTPS) can be observed. Using simple metrics in patients with CTP, CTPS was reported to vary from a few millimeters to up to 40 mm per year. Rapid CTPS/ Nelson's syndrome was associated with more severe Cushing's disease, higher adrenocorticotropic hormone (ACTH) in the year following adrenalectomy, and higher Ki67 on pituitary pathology. Complications such as apoplexy, cavernous syndrome, and visual defects were associated with higher CTPS. During follow-up, early morning ACTH, absolute variations properly reflected CTPS. Finally, CTPS was not higher after than before adrenalectomy, suggesting that cortisol deprivation after adrenalectomy does not impact CTPS in a majority of patients.Taken together, rapid CTPS/ Nelson's syndrome probably reflects the intrinsic aggressiveness of some corticotroph PitNETs. The precise molecular mechanisms related to corticotroph PitNET aggressiveness remain to be deciphered. Regular MRIs combined with intermediate morning ACTH measurements probably provide a reliable way to detect early and manage fast-growing tumors and, therefore, limit the complications.

自 60 年前首次描述纳尔逊综合征以来,考虑双侧肾上腺切除术后皮质垂体神经内分泌肿瘤 (PitNET) 的方法不断演变。如今,全球公认只有一部分皮质垂体神经内分泌肿瘤具有侵袭性。肾上腺切除术后,在 10 年的中位随访期间,约有 30% 至 40% 的患者会出现皮质营养肿瘤进展(CTP)。当 CTP 发生时,可以观察到各种 CTP(CTPS)速度。据报道,通过对 CTP 患者进行简单的度量,CTPS 的变化范围从每年几毫米到每年高达 40 毫米。快速 CTPS/Nelson's 综合征与更严重的库欣、肾上腺切除术后一年内更高的促肾上腺皮质激素和更高的垂体病理学 Ki67 有关。并发症,如脑溢血、海绵体综合征和视觉缺陷与较高的 CTPS 有关。在随访期间,清晨促肾上腺皮质激素的绝对值变化正确地反映了CTPS。最后,肾上腺切除术后的 CTPS 并不高于肾上腺切除术前,这表明肾上腺切除术后的皮质醇剥夺不会影响大多数患者的 CTPS。综上所述,快速 CTPS/Nelson's 综合征可能反映了某些皮质营养型 PitNET 的内在侵袭性。与皮质营养型PitNET侵袭性有关的确切分子机制仍有待破解。定期进行核磁共振成像和中间晨间促肾上腺皮质激素(ACTH)测量可能是早期发现和控制快速生长肿瘤的可靠方法,因此可以限制并发症的发生。
{"title":"From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update.","authors":"Laura Bessiène, Chiara Villa, Xavier Bertagna, Bertrand Baussart, Guillaume Assié","doi":"10.1055/a-2359-8649","DOIUrl":"10.1055/a-2359-8649","url":null,"abstract":"<p><p>Since the first description of Nelson syndrome 60 years ago, the way to consider corticotroph pituitary neuroendocrine tumors (PitNETs) after bilateral adrenalectomy has evolved. Today, it is globally acknowledged that only a subset of corticotroph PitNETs is aggressive.After adrenalectomy, corticotroph tumor progression (CTP) occurs in about 30 to 40% of patients during a median follow-up of 10 years. When CTP occurs, various CTP speeds (CTPS) can be observed. Using simple metrics in patients with CTP, CTPS was reported to vary from a few millimeters to up to 40 mm per year. Rapid CTPS/ Nelson's syndrome was associated with more severe Cushing's disease, higher adrenocorticotropic hormone (ACTH) in the year following adrenalectomy, and higher Ki67 on pituitary pathology. Complications such as apoplexy, cavernous syndrome, and visual defects were associated with higher CTPS. During follow-up, early morning ACTH, absolute variations properly reflected CTPS. Finally, CTPS was not higher after than before adrenalectomy, suggesting that cortisol deprivation after adrenalectomy does not impact CTPS in a majority of patients.Taken together, rapid CTPS/ Nelson's syndrome probably reflects the intrinsic aggressiveness of some corticotroph PitNETs. The precise molecular mechanisms related to corticotroph PitNET aggressiveness remain to be deciphered. Regular MRIs combined with intermediate morning ACTH measurements probably provide a reliable way to detect early and manage fast-growing tumors and, therefore, limit the complications.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"581-590"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141499979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats. 成年 Wistar 大鼠长期口服二甲双胍对骨骼的影响
Nahuel E Wanionok, María S Molinuevo, Juan M Fernández, Besada Lucas, Ana M Cortizo, Evelyn J Castillo, Jessica M Jiron, Sedlinsky Claudia, Schurman Leon, José I Aguirre, Antonio D McCarthy

Introduction: We previously showed that a 3-week oral metformin (MET) treatment enhances the osteogenic potential of bone marrow stromal cells (BMSCs) and improves several bone histomorphometric parameters in Wistar rats with metabolic syndrome (MetS). However, the skeletal effects of extended periods of MET need to be completely elucidated. Hence, in this study, the impact of a prolonged (3-month) MET treatment was investigated on bone architecture, histomorphometric and biomechanics variables, and osteogenic potential of BMSCs in Wistar rats with or without MetS.

Materials and methods: Young male Wistar rats (n=36) were randomized into four groups (n=9) that received either 20% fructose (F), MET (MET), F plus MET treatments (FMET), or drinking water alone (Veh). Rats were euthanized, blood was collected, and bones were dissected and processed for peripheral quantitative computed tomography (pQCT) analysis, static and dynamic histomorphometry, and bone biomechanics. In addition, BMSCs were isolated to determine their osteogenic potential.

Results: MET affected trabecular and cortical bone, altering bone architecture and biomechanics. Furthermore, MET increased the pro-resorptive profile of BMSCs. In addition, fructose-induced MetS practically did not affect the the structural or mechanical variables of the skeleton.

Conclusion: A 3-month treatment with MET (with or without MetS) affects bone architecture and biomechanical variables in Wistar rats.

简介:我们以前的研究表明,在患有代谢综合征(MetS)的Wistar大鼠中,口服三周二甲双胍(MET)可增强骨髓基质细胞(BMSCs)的成骨潜能,并改善骨骼组织形态学的一些参数。然而,长期服用 MET 对骨骼的影响仍未完全阐明。因此,我们研究了长期(3 个月)MET 处理对有或没有 MetS 的 Wistar 大鼠骨结构、组织形态计量学和生物力学变量以及 BMSCs 成骨潜能的影响。材料和方法:36 只年轻雄性 Wistar 大鼠被随机分为四组(n=9),分别接受 20% 果糖(F)、MET(MET)、F 加 MET 处理(FMET)或单独饮用水(Veh)。对大鼠实施安乐死,收集血液,解剖并处理骨骼,进行 pQCT 分析、静态和动态组织形态测量以及骨生物力学分析。此外,还分离了 BMSCs,以确定其成骨细胞的潜力:结果:MET影响了骨小梁和皮质骨,改变了骨结构和生物力学。此外,MET 增加了 BMSCs 的促骨吸收特性。此外,果糖诱导的 MetS 实际上并不影响骨骼的结构或机械变量:结论:为期 3 个月的 MET 治疗(无论是否存在 MetS)都会影响 Wistar 大鼠的骨骼结构和生物力学变量。
{"title":"Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats.","authors":"Nahuel E Wanionok, María S Molinuevo, Juan M Fernández, Besada Lucas, Ana M Cortizo, Evelyn J Castillo, Jessica M Jiron, Sedlinsky Claudia, Schurman Leon, José I Aguirre, Antonio D McCarthy","doi":"10.1055/a-2324-8661","DOIUrl":"10.1055/a-2324-8661","url":null,"abstract":"<p><strong>Introduction: </strong>We previously showed that a 3-week oral metformin (MET) treatment enhances the osteogenic potential of bone marrow stromal cells (BMSCs) and improves several bone histomorphometric parameters in Wistar rats with metabolic syndrome (MetS). However, the skeletal effects of extended periods of MET need to be completely elucidated. Hence, in this study, the impact of a prolonged (3-month) MET treatment was investigated on bone architecture, histomorphometric and biomechanics variables, and osteogenic potential of BMSCs in Wistar rats with or without MetS.</p><p><strong>Materials and methods: </strong>Young male Wistar rats (n=36) were randomized into four groups (n=9) that received either 20% fructose (<b><i>F</i></b>), MET (<b><i>MET</i></b>), F plus MET treatments (<b><i>FMET</i></b>), or drinking water alone (<b><i>Veh</i></b>). Rats were euthanized, blood was collected, and bones were dissected and processed for peripheral quantitative computed tomography (pQCT) analysis, static and dynamic histomorphometry, and bone biomechanics. In addition, BMSCs were isolated to determine their osteogenic potential.</p><p><strong>Results: </strong>MET affected trabecular and cortical bone, altering bone architecture and biomechanics. Furthermore, MET increased the pro-resorptive profile of BMSCs. In addition, fructose-induced MetS practically did not affect the the structural or mechanical variables of the skeleton.</p><p><strong>Conclusion: </strong>A 3-month treatment with MET (with or without MetS) affects bone architecture and biomechanical variables in Wistar rats.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"547-556"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats. 奥利多宁通过激活 PPARγ 抑制 TXNIP/NLRP3 和 NF-κB 通路,减轻糖尿病诱发的大鼠肾脏纤维化。
Gengzhen Huang, Yaodan Zhang, Yingying Zhang, Xiaotao Zhou, Yuan Xu, Huiting Wei, Xian Chen, Yuerong Ma

Introduction: Oridonin possesses remarkable anti-inflammatory, immunoregulatory properties. However, the renoprotective effects of oridonin and the underlying molecular mechanisms in diabetic nephropathy (DN). We hypothesized that oridonin could ameliorate diabetes‑induced renal fibrosis.

Methods: Streptozocin (STZ)-induced diabetic rats were provided with a high-fat diet to establish a type 2 diabetes mellitus (T2DM) animal model, and then treated with Oridonin (10, 20 mg/kg/day) for two weeks. Kidney function and renal fibrosis were assessed. High glucose-induced human renal proximal tubule epithelial cells (HK-2) were also treated with oridonin. The expression of inflammatory factors and fibrotic markers were analyzed.

Results: Oridonin treatment preserved kidney function and markedly limited the renal fibrosis size in diabetic rats. The renal fibrotic markers were inhibited in the oridonin 10 mg/kg/day and 20 mg/kg/day groups compared to the T2DM group. The expression of thioredoxin-interacting proteins/ nod-like receptor protein-3 (TXNIP/NLRP3) and nuclear factor (NF)‑κB pathway decreased, while that of peroxisome proliferator-activated receptor-gamma (PPARγ) increased in the oridonin treatment group compared to the non-treated group. In vitro, PPARγ intervention could significantly regulate the effect of oridonin on the high glucose-induced inflammatory changes in HK-2 cells.

Conclusion: Oridonin reduces renal fibrosis and preserves kidney function via the inhibition of TXNIP/NLRP3 and NF‑κB pathways by activating PPARγ in rat T2DM model, which indicates potential effect of oridonin in the treatment of DN.

简介奥利多宁具有显著的抗炎和免疫调节特性。然而,奥利多宁对糖尿病肾病(DN)的肾脏保护作用及其潜在的分子机制尚未得到研究。我们假设奥利多宁能改善糖尿病引起的肾脏纤维化:方法:用链脲佐辛(STZ)诱导的糖尿病大鼠联合高脂饮食建立 2 型糖尿病(T2DM)动物模型,然后用奥利多宁(10、20 毫克/千克/天)治疗两周。对肾功能和肾纤维化进行了评估。我们还用奥利多宁处理了高糖诱导的人肾近曲小管上皮细胞(HK-2)。此外,我们还分析了炎症因子和纤维化标志物的表达:结果:奥利多宁治疗可保护糖尿病大鼠的肾功能,并显著限制其肾脏纤维化的程度。与 T2DM 组相比,10 毫克/千克/天组和 20 毫克/千克/天组的肾纤维化标志物均受到抑制。此外,与未治疗组相比,奥利多宁治疗组 TXNIP/NLRP3 和 NF-κB 通路的表达水平降低,PPARγ 水平升高。在体外,PPARγ的干预可显著调节奥利多宁对高糖诱导的HK-2炎症变化的影响:结论:在T2DM大鼠模型中,奥利多宁通过激活PPARγ抑制TXNIP/NLRP3和NF-κB通路,减轻肾脏纤维化并保护肾功能,这表明奥利多宁对DN具有潜在的治疗作用。
{"title":"Oridonin Attenuates Diabetes‑induced Renal Fibrosis via the Inhibition of TXNIP/NLRP3 and NF‑κB Pathways by Activating PPARγ in Rats.","authors":"Gengzhen Huang, Yaodan Zhang, Yingying Zhang, Xiaotao Zhou, Yuan Xu, Huiting Wei, Xian Chen, Yuerong Ma","doi":"10.1055/a-2322-7438","DOIUrl":"10.1055/a-2322-7438","url":null,"abstract":"<p><strong>Introduction: </strong>Oridonin possesses remarkable anti-inflammatory, immunoregulatory properties. However, the renoprotective effects of oridonin and the underlying molecular mechanisms in diabetic nephropathy (DN). We hypothesized that oridonin could ameliorate diabetes‑induced renal fibrosis.</p><p><strong>Methods: </strong>Streptozocin (STZ)-induced diabetic rats were provided with a high-fat diet to establish a type 2 diabetes mellitus (T2DM) animal model, and then treated with Oridonin (10, 20 mg/kg/day) for two weeks. Kidney function and renal fibrosis were assessed. High glucose-induced human renal proximal tubule epithelial cells (HK-2) were also treated with oridonin. The expression of inflammatory factors and fibrotic markers were analyzed.</p><p><strong>Results: </strong>Oridonin treatment preserved kidney function and markedly limited the renal fibrosis size in diabetic rats. The renal fibrotic markers were inhibited in the oridonin 10 mg/kg/day and 20 mg/kg/day groups compared to the T2DM group. The expression of thioredoxin-interacting proteins/ nod-like receptor protein-3 (TXNIP/NLRP3) and nuclear factor (NF)‑κB pathway decreased, while that of peroxisome proliferator-activated receptor-gamma (PPARγ) increased in the oridonin treatment group compared to the non-treated group. In vitro, PPARγ intervention could significantly regulate the effect of oridonin on the high glucose-induced inflammatory changes in HK-2 cells.</p><p><strong>Conclusion: </strong>Oridonin reduces renal fibrosis and preserves kidney function via the inhibition of TXNIP/NLRP3 and NF‑κB pathways by activating PPARγ in rat T2DM model, which indicates potential effect of oridonin in the treatment of DN.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"536-544"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140893075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Medical and Surgical Treatment in Management of the Patients With Prolactinoma: A Single-Center Experience. 药物和手术治疗在催乳素瘤患者管理中的作用;单中心经验。
Guldana Zulfaliyeva, Ahmet Numan Demir, Semih Can Cetintas, Dilan Ozaydin, Necmettin Tanriover, Pinar Kadioglu

Background: Current guidelines recommend dopamine agonists (DA) as the primary therapeutic approach for prolactinomas; however, emerging evidence suggests that surgical intervention can also yield favorable outcomes.

Objective: To comprehensively evaluate prolactinoma patients undergoing surgical and medical treatments at our pituitary center.

Methods: Retrospective review of mMedical records from prolactinoma patients treated between 2015 and 2022 was performedwere retrospectively reviewed. The study focused on treatment outcomes and remission rates while investigating factors influencing the success of both treatment modalities in achieving remission.

Results: A total of 301 prolactinoma patients were included, of whom 199 were women. Among them, 235 were managed medically, while 66 underwent surgical intervention. The overall remission rates of patients treated with medical and surgery were similar at the final examination (Respectively respectively 82.9% and 81.8%, p=0.114). Factors associated with remission in both treatment modalities included female sex, low initial prolactin levels, small adenoma size, and absence of cavernous invasion. Compared to DA treatment, Ssurgical treatment demonstrated a higher rate of drug-free remission compared to DA treatment for microadenomas, and macroadenomas without cavernous invasion. In cases with cavernous invasion, standalone surgical treatment yielded a low rate of drug-free remission (7.7%); however, when combined with DA therapy post-surgery, remission rates increased to 66.7%.

Conclusion: Medical treatment with DAs remains the preferred option for macroadenomas with cavernous sinus invasion, and giant adenomas, with surgery reserved for selected cases to address complications. Conversely, surgery emerges as the most effective modality for achieving remission in patients with microadenomas, and macroadenomas confined to the sella. The recommendation of DAs as first-line therapy for all patients has been withdrawn in the current guidelines, and individual treatment approaches based on tumor characteristics are emphasized. Our results support this approach.

背景:目前的指南推荐多巴胺受体激动剂(DA)作为催乳素瘤的主要治疗方法:目前的指南建议将多巴胺激动剂(DA)作为催乳素瘤的主要治疗方法;然而,新出现的证据表明,手术干预也能产生良好的疗效:全面评估本垂体中心接受手术和药物治疗的泌乳素瘤患者:对2015年至2022年间接受治疗的泌乳素瘤患者的病历进行回顾性审查。研究重点是治疗结果和缓解率,同时调查影响两种治疗方式成功实现缓解的因素:共纳入 301 名泌乳素瘤患者,其中 199 人为女性。其中 235 人接受了药物治疗,66 人接受了手术治疗。最终检查结果显示,药物治疗和手术治疗患者的总体缓解率相似(分别为 82.9% 和 81.8%,P=0.114)。两种治疗方式的缓解率相关因素包括女性、初始催乳素水平低、腺瘤体积小以及无海绵体侵犯。对于微腺瘤和无海绵体侵犯的大腺瘤,手术治疗的无药缓解率高于DA治疗。在有海绵体侵犯的病例中,独立手术治疗的无药缓解率较低(7.7%);然而,如果术后结合DA治疗,缓解率则增至66.7%:结论:对于有海绵窦侵犯的大腺瘤和巨大腺瘤,使用DAs进行药物治疗仍是首选方案,而手术则保留给特定病例以解决并发症。相反,对于微腺瘤和局限于椎间盘的大腺瘤患者,手术则是获得缓解的最有效方式。目前的指南已不再建议将 DAs 作为所有患者的一线治疗方法,而是强调根据肿瘤特征采取个性化的治疗方法。我们的研究结果支持这一观点。
{"title":"Role of Medical and Surgical Treatment in Management of the Patients With Prolactinoma: A Single-Center Experience.","authors":"Guldana Zulfaliyeva, Ahmet Numan Demir, Semih Can Cetintas, Dilan Ozaydin, Necmettin Tanriover, Pinar Kadioglu","doi":"10.1055/a-2364-6027","DOIUrl":"10.1055/a-2364-6027","url":null,"abstract":"<p><strong>Background: </strong>Current guidelines recommend dopamine agonists (DA) as the primary therapeutic approach for prolactinomas; however, emerging evidence suggests that surgical intervention can also yield favorable outcomes.</p><p><strong>Objective: </strong>To comprehensively evaluate prolactinoma patients undergoing surgical and medical treatments at our pituitary center.</p><p><strong>Methods: </strong>Retrospective review of mMedical records from prolactinoma patients treated between 2015 and 2022 was performedwere retrospectively reviewed. The study focused on treatment outcomes and remission rates while investigating factors influencing the success of both treatment modalities in achieving remission.</p><p><strong>Results: </strong>A total of 301 prolactinoma patients were included, of whom 199 were women. Among them, 235 were managed medically, while 66 underwent surgical intervention. The overall remission rates of patients treated with medical and surgery were similar at the final examination (Respectively respectively 82.9% and 81.8%, p=0.114). Factors associated with remission in both treatment modalities included female sex, low initial prolactin levels, small adenoma size, and absence of cavernous invasion. Compared to DA treatment, Ssurgical treatment demonstrated a higher rate of drug-free remission compared to DA treatment for microadenomas, and macroadenomas without cavernous invasion. In cases with cavernous invasion, standalone surgical treatment yielded a low rate of drug-free remission (7.7%); however, when combined with DA therapy post-surgery, remission rates increased to 66.7%.</p><p><strong>Conclusion: </strong>Medical treatment with DAs remains the preferred option for macroadenomas with cavernous sinus invasion, and giant adenomas, with surgery reserved for selected cases to address complications. Conversely, surgery emerges as the most effective modality for achieving remission in patients with microadenomas, and macroadenomas confined to the sella. The recommendation of DAs as first-line therapy for all patients has been withdrawn in the current guidelines, and individual treatment approaches based on tumor characteristics are emphasized. Our results support this approach.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"570-580"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peroneal Nerve Entrapment in Diabetes Mellitus. 糖尿病患者的腓肠神经卡压。
Iliana Stamatiou, Melina Ntoga, Nikolaos Papanas

This narrative mini-review discusses the association between peroneal nerve entrapment (PEN) and diabetes mellitus (DM). Generally, PEN is not a common cause of peripheral neuropathy in DM. Poor glycaemic control and DM duration are powerful risk factors for PEN. Underlying mechanisms involve neurodegeneration and entrapment of the peroneal nerve. Patients tend to present with chronic leg pain, gradual foot drop, steppage gait, or weakness of ankle dorsiflexion. Electrodiagnostic and imaging studies are very useful in diagnosis to determine the level at which entrapment occurs. Treatment varies based on the aetiology and severity of symptoms. It is initially conservative. Surgical nerve decompression management is required when entrapment is refractory to non-operative options.

本篇微型综述旨在讨论腓总神经卡压(PEN)与糖尿病(DM)之间的关系。一般来说,腓总神经卡压并不是导致糖尿病周围神经病变的常见原因。血糖控制不佳和糖尿病持续时间长是导致腓总神经卡压的重要风险因素。其根本机制涉及腓总神经的神经变性和卡压。患者往往表现为慢性腿痛、足部逐渐下垂、步态蹒跚或踝关节外展无力。电诊断和影像学检查对诊断非常有用,可确定发生卡压的水平。治疗方法因病因和症状严重程度而异。最初是保守治疗。如果非手术治疗无效,则需要进行手术神经减压治疗。
{"title":"Peroneal Nerve Entrapment in Diabetes Mellitus.","authors":"Iliana Stamatiou, Melina Ntoga, Nikolaos Papanas","doi":"10.1055/a-2372-9964","DOIUrl":"10.1055/a-2372-9964","url":null,"abstract":"<p><p>This narrative mini-review discusses the association between peroneal nerve entrapment (PEN) and diabetes mellitus (DM). Generally, PEN is not a common cause of peripheral neuropathy in DM. Poor glycaemic control and DM duration are powerful risk factors for PEN. Underlying mechanisms involve neurodegeneration and entrapment of the peroneal nerve. Patients tend to present with chronic leg pain, gradual foot drop, steppage gait, or weakness of ankle dorsiflexion. Electrodiagnostic and imaging studies are very useful in diagnosis to determine the level at which entrapment occurs. Treatment varies based on the aetiology and severity of symptoms. It is initially conservative. Surgical nerve decompression management is required when entrapment is refractory to non-operative options.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"558-561"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141763484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NT-pro-BNP Level is Related to Left Ventricular Remodeling in Patients With Primary Aldosteronism. NT-pro-BNP水平与原发性醛固酮增多症患者左心室重塑有关
Tao Wu, Chenxiao Xu, Lu Tang, Xi Wu, Pengfei Peng, Xun Yue, Wei Cheng, Shuai He, Lei Li, Yucheng Chen, Yan Ren, Jiayu Sun

Aims: To assess the relationship between the left ventricular remodeling parameters of cardiac magnetic resonance and NT-pro-BNP in patients with primary aldosteronism (PA).

Methods: Seventy-four PA and 39 essential hypertension patients were prospectively recruited and underwent cardiac magnetic resonance. Plasma NT-pro-BNP was measured before patients underwent cardiac magnetic resonance. Left ventricular remodeling parameters were defined as left ventricular function parameters, T1 mapping parameters, and strain parameters. Differences in continuous variables between two groups were analyzed using Student's t-test or Mann-Whitney U test. Differences in categorical variables between two groups were analyzed by chi-squared test. Spearman's correlation and linear regression were used to analyze the relationships between left ventricular remodeling parameters and plasma NT-Pro-BNP level. P<0.05 was considered as statistically significant.

Results: Patients with PA demonstrated higher NT-pro-BNP [86.0 (49.5, 145.5) vs. 45.0 (28.5, 73.5) pg/mL, P=0.001] and Native T1 (1227±41 vs. 1206±43 ms, P=0.015) level than essential hypertension patients. Compared to patients with normal NT-pro-BNP levels, those with abnormal levels demonstrated different left ventricular remodeling parameters. NT-pro-BNP level was independently related to native T1 (β=0.316, P=0.006), extracellular volume (β=0.419, P<0.001), short-axis global circumferential strain (β=0.429, P<0.001), four-chamber global longitudinal strain (β=0.332, P=0.002), and four-chamber global radial strain (β=-0.334, P=0.004) in patients after adjusting for baseline characteristics.

Conclusions: NT-pro-BNP level was related to left ventricular remodeling parameters derived from cardiac magnetic resonance in patients with PA. This result implies that clinicians should pay attention to NT-pro-BNP assessment in patients with PA in routine clinical assessment.

目的:评估原发性醛固酮增多症(PA)患者心脏磁共振左心室重塑参数与NT-pro-BNP之间的关系:前瞻性招募了74名原发性醛固酮增多症患者和39名原发性高血压患者,并对他们进行了心脏磁共振检查。在患者接受心脏磁共振检查前测量血浆NT-pro-BNP。左心室重塑参数定义为左心室功能参数、T1映射参数和应变参数。两组间连续变量的差异采用学生 t 检验或 Mann-Whitney U 检验进行分析。两组间分类变量的差异采用卡方检验。斯皮尔曼相关和线性回归用于分析左心室重塑参数与血浆NT-Pro-BNP水平之间的关系。结果PA患者的NT-pro-BNP[86.0 (49.5, 145.5) vs. 45.0 (28.5, 73.5) pg/mL,P=0.001]和Native T1 (1227±41 vs. 1206±43 ms,P=0.015)水平高于原发性高血压患者。与NT-pro-BNP水平正常的患者相比,NT-pro-BNP水平异常的患者表现出不同的左心室重塑参数。NT-pro-BNP水平与心脏磁共振得出的PA患者左心室重塑参数有关。这一结果提示临床医生在常规临床评估中应关注 PA 患者的 NT-pro-BNP 评估。
{"title":"NT-pro-BNP Level is Related to Left Ventricular Remodeling in Patients With Primary Aldosteronism.","authors":"Tao Wu, Chenxiao Xu, Lu Tang, Xi Wu, Pengfei Peng, Xun Yue, Wei Cheng, Shuai He, Lei Li, Yucheng Chen, Yan Ren, Jiayu Sun","doi":"10.1055/a-2348-4468","DOIUrl":"10.1055/a-2348-4468","url":null,"abstract":"<p><strong>Aims: </strong>To assess the relationship between the left ventricular remodeling parameters of cardiac magnetic resonance and NT-pro-BNP in patients with primary aldosteronism (PA).</p><p><strong>Methods: </strong>Seventy-four PA and 39 essential hypertension patients were prospectively recruited and underwent cardiac magnetic resonance. Plasma NT-pro-BNP was measured before patients underwent cardiac magnetic resonance. Left ventricular remodeling parameters were defined as left ventricular function parameters, T1 mapping parameters, and strain parameters. Differences in continuous variables between two groups were analyzed using Student's t-test or Mann-Whitney U test. Differences in categorical variables between two groups were analyzed by chi-squared test. Spearman's correlation and linear regression were used to analyze the relationships between left ventricular remodeling parameters and plasma NT-Pro-BNP level. P<0.05 was considered as statistically significant.</p><p><strong>Results: </strong>Patients with PA demonstrated higher NT-pro-BNP [86.0 (49.5, 145.5) vs. 45.0 (28.5, 73.5) pg/mL, P=0.001] and Native T1 (1227±41 vs. 1206±43 ms, P=0.015) level than essential hypertension patients. Compared to patients with normal NT-pro-BNP levels, those with abnormal levels demonstrated different left ventricular remodeling parameters. NT-pro-BNP level was independently related to native T1 (β=0.316, P=0.006), extracellular volume (β=0.419, P<0.001), short-axis global circumferential strain (β=0.429, P<0.001), four-chamber global longitudinal strain (β=0.332, P=0.002), and four-chamber global radial strain (β=-0.334, P=0.004) in patients after adjusting for baseline characteristics.</p><p><strong>Conclusions: </strong>NT-pro-BNP level was related to left ventricular remodeling parameters derived from cardiac magnetic resonance in patients with PA. This result implies that clinicians should pay attention to NT-pro-BNP assessment in patients with PA in routine clinical assessment.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11464161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142121423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association Between Oxidative Stress and Sperm Parameters in Patients with Acromegaly. 肢端肥大症患者的氧化应激与精子参数之间的关系
Serdar Sahin, Ebru Cicek, Banu Betül Kocaman, Cem Sulu, Hande Mefkure Ozkaya, Hamdi Ozkara, Dildar Konukoglu, Pinar Kadioglu

Objective: Spermatozoa are susceptible to oxidative radicals when antioxidant defenses are inadequate. The extent to which oxidative radicals contribute to sperm damage in patients with acromegaly remains unclear. This study aimed to investigate and elucidate this relationship.

Methods: The overall status of oxidants and antioxidants in both seminal plasma and serum of patients with acromegaly compared to a control group of healthy individuals was investigated. In addition, sperm parameters, including important measures such as growth hormone and insulin-like growth factor-1 concentrations.

Results: Twenty-two patients with acromegaly with controlled disease and 14 healthy controls were included. The total oxidant status was significantly higher in the semen samples of the patients with acromegaly. A negative correlation was found between sperm total oxidant status and total sperm count and sperm concentration. Similarly, a negative correlation was found between the total sperm count and the sperm oxidative stress index. In individuals diagnosed with acromegaly, there was a statistically significant increase in sperm growth hormone levels. Conversely, the level of insulin-like growth factor 1 was significantly increased in the sperm of the control group, which consisted of healthy individuals. The correlation analysis revealed a significant relationship between venous total oxidant status and growth hormone levels in semen.

Conclusion: The elevated levels of reactive oxygen radicals in individuals with acromegaly suggest a possible link between oxidative stress and its effects on semen quality.

目的当抗氧化防御功能不足时,精子很容易受到氧化自由基的影响。氧化自由基在多大程度上导致肢端肥大症患者精子受损仍不清楚。本研究旨在调查和阐明这种关系:方法:与健康对照组相比,本研究调查了肢端肥大症患者精浆和血清中氧化剂和抗氧化剂的总体状况。此外,还研究了精子参数,包括生长激素和胰岛素样生长因子-1浓度等重要指标:结果:研究对象包括22名病情得到控制的肢端肥大症患者和14名健康对照者。在肢端肥大症患者的精液样本中,总氧化状态明显较高。精子总氧化状态与精子总数和精子浓度之间呈负相关。同样,精子总数与精子氧化应激指数之间也呈负相关。在确诊为肢端肥大症的患者中,精子生长激素水平有显著的统计学增长。相反,在由健康人组成的对照组中,胰岛素样生长因子 1 的水平则明显升高。相关分析表明,静脉总氧化状态与精液中的生长激素水平之间存在明显关系:结论:肢端肥大症患者体内活性氧自由基水平的升高表明,氧化应激及其对精液质量的影响之间可能存在联系。
{"title":"The Association Between Oxidative Stress and Sperm Parameters in Patients with Acromegaly.","authors":"Serdar Sahin, Ebru Cicek, Banu Betül Kocaman, Cem Sulu, Hande Mefkure Ozkaya, Hamdi Ozkara, Dildar Konukoglu, Pinar Kadioglu","doi":"10.1055/a-2329-2998","DOIUrl":"10.1055/a-2329-2998","url":null,"abstract":"<p><strong>Objective: </strong>Spermatozoa are susceptible to oxidative radicals when antioxidant defenses are inadequate. The extent to which oxidative radicals contribute to sperm damage in patients with acromegaly remains unclear. This study aimed to investigate and elucidate this relationship.</p><p><strong>Methods: </strong>The overall status of oxidants and antioxidants in both seminal plasma and serum of patients with acromegaly compared to a control group of healthy individuals was investigated. In addition, sperm parameters, including important measures such as growth hormone and insulin-like growth factor-1 concentrations.</p><p><strong>Results: </strong>Twenty-two patients with acromegaly with controlled disease and 14 healthy controls were included. The total oxidant status was significantly higher in the semen samples of the patients with acromegaly. A negative correlation was found between sperm total oxidant status and total sperm count and sperm concentration. Similarly, a negative correlation was found between the total sperm count and the sperm oxidative stress index. In individuals diagnosed with acromegaly, there was a statistically significant increase in sperm growth hormone levels. Conversely, the level of insulin-like growth factor 1 was significantly increased in the sperm of the control group, which consisted of healthy individuals. The correlation analysis revealed a significant relationship between venous total oxidant status and growth hormone levels in semen.</p><p><strong>Conclusion: </strong>The elevated levels of reactive oxygen radicals in individuals with acromegaly suggest a possible link between oxidative stress and its effects on semen quality.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"498-506"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes and Road Traffic. 糖尿病与道路交通
Oliver Ebert, Barbara Bohn, Bernd Bertram, Barbara Buchberger, Hermann Finck, Jürgen Hoß, Peter Hübner, Laura Krabbe, Bernhard Kulzer, Eva Küstner, Bernhard Lachenmayr, Klaus-Dieter Lemmen, Friedhelm Petry, Kurt Rinnert, Markus Salomon, Wolfgang Schütt, Reinhard W Holl, Stephan Maxeiner, Wolfgang Wagener
{"title":"Diabetes and Road Traffic.","authors":"Oliver Ebert, Barbara Bohn, Bernd Bertram, Barbara Buchberger, Hermann Finck, Jürgen Hoß, Peter Hübner, Laura Krabbe, Bernhard Kulzer, Eva Küstner, Bernhard Lachenmayr, Klaus-Dieter Lemmen, Friedhelm Petry, Kurt Rinnert, Markus Salomon, Wolfgang Schütt, Reinhard W Holl, Stephan Maxeiner, Wolfgang Wagener","doi":"10.1055/a-2166-6928","DOIUrl":"10.1055/a-2166-6928","url":null,"abstract":"","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"481-496"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139941394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical Coherence Tomography Angiography Evaluation of Retinochoroidal Microvascular Circulation Differences in Pregnant Women with Pregestational and Gestational Diabetes Mellitus. 光学相干断层扫描血管造影术评估妊娠期糖尿病孕妇和妊娠期糖尿病孕妇视网膜脉络膜微血管循环的差异。
Çisil Erkan Pota, Mehmet E Doğan, Gül Alkan Bülbül, Cem Y Sanhal, Ali Pota

Purpose: In this study, the changes in microvascular circulation caused by pregestational and gestational diabetes were observed, without focusing on retinal findings, to reveal the effect of diabetes regulation.

Methods: A total of 135 subjects were included: 30 with gestational diabetes (GDM), 30 pregestational diabetes (PGDM), 30 healthy pregnant normoglycemic subjects, and 45 healthy non-pregnant subjects. All subjects were examined by optical coherence tomography (OCT) and angiography. The retina, retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), choroidal thickness (CT), superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC), vascular density (VD), and foveal avascular zone (FAZ) areas were measured.

Results: The foveal VD of SCP and DCP was significantly lower in the PGDM and GDM groups compared to the control groups (p:0.006 and p:0.001, respectively). CC VD was significantly higher in all pregnant groups compared to non-pregnant controls (p<0.001). The choroidal thickness values were highest in the healthy pregnant group and lowest in the PGDM group. There was no significant difference in FAZ area, retina, RNFL and GCL thickness between the groups. In the PGDM group, a negative correlation was observed between the FAZ area and the HbA1c level (r:- 0.417, p:0.043).

Conclusion: There was a decrease in vascular density in pregnant women with diabetes compared to healthy pregnant women and controls. In the pregnant group with PGDM, a narrowing of the FAZ area was observed with increasing worsening of diabetes control. Diabetes type and glycemic control could influence the microvascular changes even in the absence of clinical or retinal findings.

目的:本研究观察妊娠前糖尿病和妊娠期糖尿病引起的微血管循环的变化,不关注视网膜的发现,以揭示糖尿病调节的影响:方法:共纳入 135 名受试者:方法:共纳入 135 名受试者:30 名妊娠糖尿病(GDM)患者、30 名妊娠前期糖尿病(PGDM)患者、30 名血糖正常的健康孕妇和 45 名健康的非孕妇。所有受试者均接受了光学相干断层扫描(OCT)和血管造影检查。测量了视网膜、视网膜神经纤维层(RNFL)、神经节细胞层(GCL)、脉络膜厚度(CT)、浅层毛细血管丛(SCP)、深层毛细血管丛(DCP)、绒毛膜(CC)、血管密度(VD)和眼窝无血管区(FAZ)的面积:结果:与对照组相比,PGDM 组和 GDM 组 SCP 和 DCP 的眼窝 VD 明显较低(分别为 p:0.006 和 p:0.001)。与非妊娠对照组相比,所有妊娠组的 CC VD 均明显升高(P:0.006 和 P:0.001):与健康孕妇和对照组相比,糖尿病孕妇的血管密度有所下降。在患有 PGDM 的孕妇组中,观察到 FAZ 区域随着糖尿病控制的恶化而变窄。即使没有临床或视网膜发现,糖尿病类型和血糖控制也会影响微血管的变化。
{"title":"Optical Coherence Tomography Angiography Evaluation of Retinochoroidal Microvascular Circulation Differences in Pregnant Women with Pregestational and Gestational Diabetes Mellitus.","authors":"Çisil Erkan Pota, Mehmet E Doğan, Gül Alkan Bülbül, Cem Y Sanhal, Ali Pota","doi":"10.1055/a-2316-3903","DOIUrl":"10.1055/a-2316-3903","url":null,"abstract":"<p><strong>Purpose: </strong>In this study, the changes in microvascular circulation caused by pregestational and gestational diabetes were observed, without focusing on retinal findings, to reveal the effect of diabetes regulation.</p><p><strong>Methods: </strong>A total of 135 subjects were included: 30 with gestational diabetes (GDM), 30 pregestational diabetes (PGDM), 30 healthy pregnant normoglycemic subjects, and 45 healthy non-pregnant subjects. All subjects were examined by optical coherence tomography (OCT) and angiography. The retina, retinal nerve fiber layer (RNFL), ganglion cell layer (GCL), choroidal thickness (CT), superficial capillary plexus (SCP), deep capillary plexus (DCP), choriocapillaris (CC), vascular density (VD), and foveal avascular zone (FAZ) areas were measured.</p><p><strong>Results: </strong>The foveal VD of SCP and DCP was significantly lower in the PGDM and GDM groups compared to the control groups (p:0.006 and p:0.001, respectively). CC VD was significantly higher in all pregnant groups compared to non-pregnant controls (p<0.001). The choroidal thickness values were highest in the healthy pregnant group and lowest in the PGDM group. There was no significant difference in FAZ area, retina, RNFL and GCL thickness between the groups. In the PGDM group, a negative correlation was observed between the FAZ area and the HbA1c level (r:- 0.417, p:0.043).</p><p><strong>Conclusion: </strong>There was a decrease in vascular density in pregnant women with diabetes compared to healthy pregnant women and controls. In the pregnant group with PGDM, a narrowing of the FAZ area was observed with increasing worsening of diabetes control. Diabetes type and glycemic control could influence the microvascular changes even in the absence of clinical or retinal findings.</p>","PeriodicalId":94001,"journal":{"name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","volume":" ","pages":"522-530"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1